This research endeavor delved into the bactericidal mechanisms of CAP against Pseudomonas aeruginosa (P. aeruginosa), employing both protein oxidation and transcriptome analysis for a comprehensive understanding. The findings unveiled that CAP treatment, through the generation of Reactive Oxygen Species (ROS) and Reactive Nitrogen Species (RNS), induced direct cell membrane disruption and intracellular protein oxidation. Transcriptome profiling revealed notable disparities in gene expression patterns between CAP-treated samples and untreated controls. Specifically, the A5 treatment (air-CAP exposure for 5 min), N5 treatment (nitrogen-CAP exposure for 5 min), and N9 treatment (nitrogen-CAP exposure for 9 min) identified 1457, 95, and 885 differentially expressed genes (DEGs), respectively. These alterations indicate that CAP treatment disrupts bacterial cellular structure, motility, colonization capabilities, and protein secretion pathways, inhibiting biofilm formation and nutrient acquisition. Intriguingly, the N9 treatment was observed to cause substantial internal damage to bacterial structures, including flagella and ribosomes via RNS. Conversely, the A5 treatment rapidly disrupted the cell's external surface and metabolic activity via ROS, resulting in extensive oxidative damage and rapid efflux of cellular components. These observations suggest that CAP treatment effectively inhibits P. aeruginosa by targeting its internal and external structures.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.foodres.2025.115974 | DOI Listing |
J Biomater Appl
March 2025
Department of Chemistry, School of Pharmacy, North Sichuan Medical College, Nanchong, China.
Colorectal cancer is the fourth leading cause of cancer-related deaths worldwide. Capecitabine is a chemotherapeutic agent commonly used for the treatment of colon cancer. To realize local sustained release, promote efficient local intracellular transport, and mitigate the systemic toxic effects of capecitabine, a capecitabine prodrug, capecitabine-poly (p-dioxanone) (Cap-PPDO), was successfully synthesized.
View Article and Find Full Text PDFCureus
February 2025
Department of Intensive Care Medicine, Unidade Local de Saúde Loures Odivelas, Loures, PRT.
Panton-Valentine leukocidin (PVL)-producing is a rare but clinically significant cause of community-acquired pneumonia (CAP). This toxin leads to extensive tissue destruction and severe inflammation, often progressing to necrotizing pneumonia, septic shock, and multiorgan failure, representing a challenge in medical practice due to its rapid progression and poor prognosis. We discuss a case of a 65-year-old diabetic male who developed severe CAP leading to septic shock, respiratory failure, and multiorgan dysfunction.
View Article and Find Full Text PDFCurr Pharm Des
March 2025
Pharmacology and Drug Discovery Research Laboratory, Division of Life Sciences; Institute of Advanced Study in Science and Technology (IASST), Vigyan Path, Guwahati, PIN-781035 Assam, India.
Introduction: In recent decades, Cold Atmospheric Plasma (CAP) has become increasingly popular in healthcare for managing diseases, especially skin cancer. This study aimed to assess the preclinical safety of an indigenously developed dielectric barrier discharge-CAP device and its cytotoxic efficacy against melanoma cells while adhering to OECD 402 guidelines for acute dermal toxicity study. The safety evaluation includes ex vivo studies on mouse peritoneal exudates and in vivo acute dermal toxicity tests on Wistar rats.
View Article and Find Full Text PDFBackground: Cold atmospheric plasma (CAP) has shown good clinical efficacy in treating chronic wounds, but its superiority over conventional treatment is still under debate. This meta-analysis systematically analyzed the clinical efficacy of CAP compared to control therapy.
Methods: Relevant literature was obtained online according to PRISMA guidelines.
BMC Endocr Disord
March 2025
Department of Cardiovascular Medicine, Jiujiang City Key Laboratory of Cell Therapy, Jiujiang NO.1 People's Hospital, The First Hospital of Jiujiang, Jiujiang, 332000, China.
Background: Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most common chronic liver disease, also considered a metabolic syndrome, and is associated with poor prognosis. eGDR (estimated glucose disposal rate) is a new biomarker to assessment insulin resistance (IR). The association between eGDR and MASLD and liver fibrosis is currently unclear.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!